Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Fda crawled date : 2022 - 02 - 14 save search
PharmaCyte Biotech Updates Status of Investigational New Drug Application to FDA
Published: 2022-02-14 (Crawled : 15:30) - biospace.com/
PMCB | $2.15 1.42% 1.4% 7.9K
|
Manufacturing
|
| O: -2.31%
H: 1.9%
C: -3.79%
new drug fda application drug biotech iot
Axcella Therapeutics Announces FDA Fast Track Designation for AXA1125 in NASH
Published: 2022-02-14 (Crawled : 14:30) - biospace.com/
AXLA | $4.58 -56.33% 42K
|
Health Technology
|
| O: 1.14%
H: 7.34%
C: -5.65%
axa1125 fast track designation fda fast track therapeutics cel fda fast track nash designation
Cidara Therapeutics Announces FDA Acceptance of its Investigational New Drug Application for CD388 for Universal Prevention and Treatment of Influenza
Published: 2022-02-14 (Crawled : 13:30) - globenewswire.com
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.0%
H: 0.16%
C: -1.26%
CDTX | News | $0.5135 -24.6% -32.62% 3.7M
|
Health Technology
|
| O: 0.0%
H: 2.6%
C: -0.46%
cd388 new drug treatment fda application drug therapeutics fda acceptance influenza
Global Immunoassay Market Report 2022: FDA Grants Breakthrough Device to Multiplex Immunoassay
Published: 2022-02-14 (Crawled : 13:00) - prnewswire.com
TMO | News | $548.38 0.66% 0.29% 1.5M
|
Health Technology
|
| O: -2.67%
H: 0.75%
C: -0.59%
BIO | $280.13 0.14% 0.0% 180K
|
Health Technology
|
| O: -1.81%
H: 2.28%
C: -0.41%
BDX | $233.88 -0.1% 0.0% 770K
|
Health Technology
|
| O: -0.63%
H: 0.53%
C: -0.07%
fda device report grant granted
ASCENSIA DIABETES CARE ANNOUNCES FDA APPROVAL OF THE EVERSENSE E3 CONTINUOUS GLUCOSE MONITORING SYSTEM FOR USE FOR UP TO 6 MONTHS
Published: 2022-02-14 (Crawled : 12:30) - prnewswire.com
SENS | $0.3988 -0.1% 0.0% 2.2M
|
Electronic Technology
|
| O: -28.66%
H: 2.62%
C: -7.86%
fda fda approval approval system diabetes eversense
Motus GI Receives FDA Clearance to Market the Pure-Vu® EVS System
Published: 2022-02-14 (Crawled : 12:30) - biospace.com/
MOTS | $0.0758 -46.17% 200K
|
Health Technology
|
| O: 39.29%
H: 9.8%
C: -25.64%
fda clearance system fda clearance
U.S. FDA Grants Orphan Drug Designation to BCMA CAR-T Cell Therapy Co-Developed by Innovent and IASO Bio
Published: 2022-02-14 (Crawled : 01:00) - prnewswire.com
LLY | News | $731.33 0.69% 0.0% 2.3M
|
Health Technology
|
| O: -2.3%
H: 1.23%
C: 0.29%
INCY | $51.92 -0.82% -0.83% 1.8M
|
Health Technology
|
| O: -0.94%
H: 0.21%
C: -0.69%
fda car-t drug drug designation cel orphan drug therapy grant t-cell designation
U.S. FDA Grants Orphan Drug Designation to BCMA CAR-T Cell Therapy Co-Developed by IASO Bio and Innovent
Published: 2022-02-14 (Crawled : 01:00) - prnewswire.com
LLY | News | $731.33 0.69% 0.0% 2.3M
|
Health Technology
|
| O: -2.3%
H: 1.23%
C: 0.29%
INCY | $51.92 -0.82% -0.83% 1.8M
|
Health Technology
|
| O: -0.94%
H: 0.21%
C: -0.69%
fda car-t drug drug designation cel orphan drug therapy grant t-cell designation
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.